Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis

被引：58

作者：

Frohman, EM

Havrdova, E

Lublin, F

Barkhof, F

Achiron, A

Sharief, MK

Stuve, O

Racke, MK

Steinman, L

Weiner, H

Olek, M

Zivadinov, R

Corboy, J

Raine, C

Cutter, G

Richert, J

Filippi, M

机构：

[1] Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA

[2] Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75235 USA

[3] Charles Univ Prague, Dept Neurol, CR-11636 Prague 1, Czech Republic

[4] CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA

[5] Vrije Univ Amsterdam, Dept Radiol, Med Ctr, NL-1081 HV Amsterdam, Netherlands

[6] Chaim Sheba Med Ctr, Multiple Sclerosis Ctr, IL-52621 Tel Hashomer, Israel

[7] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel

[8] Guys Hosp, Dept Neurol, London SE1 9RT, England

[9] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA

[10] Harvard Univ, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA

[11] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA

[12] Univ Buffalo, Jacobs Neurol Inst, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Buffalo, NY USA

[13] Univ Colorado, Dept Neurol, Denver, CO 80202 USA

[14] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA

[15] Univ Alabama, Dept Biostat, Tuscaloosa, AL 35487 USA

[16] Natl Multiple Sclerosis Soc, Res Program, New York, NY USA

[17] Natl Multiple Sclerosis Soc, Clin Program, New York, NY USA

[18] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy

[19] Univ Milan, Osped San Raffaele, I-20132 Milan, Italy

来源：

ARCHIVES OF NEUROLOGY | 2006年 / 63卷 / 04期

关键词：

D O I：

10.1001/archneur.63.4.614

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：614 / 619

页数：6

共 70 条

[31]

Iannucci G, 2000, AM J NEURORADIOL, V21, P1034

[32] SILENT BRAIN-LESIONS IN PATIENTS WITH ISOLATED IDIOPATHIC OPTIC NEURITIS - A CLINICAL AND NUCLEAR-MAGNETIC-RESONANCE IMAGING STUDY [J].

JACOBS, L ;

KINKEL, PR ;

KINKEL, WR .

ARCHIVES OF NEUROLOGY, 1986, 43 (05) :452-455

[33] Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. [J].

Jacobs, LD ;

Beck, RW ;

Simon, JH ;

Kinkel, RP ;

Brownscheidle, CM ;

Murray, TJ ;

Simonian, NA ;

Slasor, PJ ;

Sandrock, AW .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :898-904

[34] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].

Jacobs, LD ;

Cookfair, DL ;

Rudick, RA ;

Herndon, RM ;

Richert, JR ;

Salazar, AM ;

Fischer, JS ;

Goodkin, DE ;

Granger, CV ;

Simon, JH ;

Alam, JJ ;

Bartoszak, DM ;

Bourdette, DN ;

Braiman, J ;

Brownscheidle, CM ;

Coats, ME ;

Cohan, SL ;

Dougherty, DS ;

Kinkel, RP ;

Mass, MK ;

Munschauer, FE ;

Priore, RL ;

Pullicino, PM ;

Scherokman, BJ ;

WeinstockGuttman, B ;

Whitman, RH ;

Baird, WC ;

Fillmore, M ;

Bona, LM ;

ColonRuiz, ME ;

Nadine, BS ;

Donovan, A ;

Bennett, S ;

Kieffer, YM ;

Umhauer, MA ;

Miller, CE ;

Kilic, AK ;

Sargent, EL ;

Schachter, M ;

Shucard, DW ;

Weider, V ;

Catalano, BA ;

Cervi, JM ;

Czekay, C ;

Farrell, JL ;

Filippini, JS ;

Matyas, RC ;

Michienzi, KE ;

Ito, M ;

OMalley, JA .

ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294

[35] Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability [J].

Johnson, KP ;

Brooks, BR ;

Cohen, JA ;

Ford, CC ;

Goldstein, J ;

Lisak, RP ;

Myers, LW ;

Panitch, HS ;

Rose, JW ;

Schiffer, RB ;

Vollmer, T ;

Weiner, LP ;

Wolinsky, JS .

NEUROLOGY, 1998, 50 (03) :701-708

[36] COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

JOHNSON, KP ;

BROOKS, BR ;

COHEN, JA ;

FORD, CC ;

GOLDSTEIN, J ;

LISAK, RP ;

MYERS, LW ;

PANITCH, HS ;

ROSE, JW ;

SCHIFFER, RB ;

VOLLMER, T ;

WEINER, LP ;

WOLINSKY, JS ;

BIRD, SJ ;

CONSTANTINESCU, C ;

KOLSON, DL ;

GONZALEZSCARANO, F ;

BRENNAN, D ;

PFOHL, D ;

MANDLER, RN ;

ROSENBERG, GA ;

JEFFREY, C ;

BARGER, GR ;

GANDHI, B ;

MOORE, PM ;

ROGERS, LR ;

LISAK, D ;

SMITH, L ;

ELLISON, GW ;

BAUMHEFNER, RW ;

CRAIG, SL ;

JALBUT, SS ;

KATZ, E ;

CONWAY, KL ;

BURNS, JB ;

SHIBA, C ;

GIANG, DW ;

PETRIE, MD ;

GUARNACCIA, JB ;

ANDERSON, S ;

MCKEON, A ;

MCCARTHY, M ;

THOMAS, AB ;

VRIESENDORP, FJ ;

AUSTIN, SG ;

LINDSEY, JW ;

DIMACHKIE, M ;

CERRETA, E ;

KACHUCK, N ;

MCCARTHY, KA .

NEUROLOGY, 1995, 45 (07) :1268-1276

[37] Longitudinal brain volume measurement in multiple sclerosis - Rate of brain atrophy is independent of the disease subtype [J].

Kalkers, NF ;

Ameziane, N ;

Bot, JCJ ;

Minneboo, A ;

Polman, CH ;

Barkhof, F .

ARCHIVES OF NEUROLOGY, 2002, 59 (10) :1572-1576

[38] Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis [J].

Kapeller, P ;

Brex, PA ;

Chard, D ;

Dalton, C ;

Griffin, CM ;

McLean, MA ;

Parker, GJM ;

Thompson, AJ ;

Miller, DH .

MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (03) :207-210

[39] Interferon beta-1b in secondary progressive MS - A combined analysis of the two trials [J].

Kappos, L ;

Weinshenker, B ;

Pozzilli, C ;

Thompson, AJ ;

Dahlke, F ;

Beckmann, K ;

Polman, C ;

McFarland, H .

NEUROLOGY, 2004, 63 (10) :1779-1787

[40]

KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444

← 1 2 3 4 5 6 7 →